D
Protagonist Therapeutics, Inc. PTGX
$58.36 $2.173.86% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income 52.04M 56.19M 275.19M 170.85M 169.95M
Total Depreciation and Amortization 2.86M 2.88M 2.90M 3.19M 3.37M
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 34.18M 32.46M 28.68M 27.60M 26.03M
Change in Net Operating Assets -49.54M 245.41M -122.61M 28.65M 32.19M
Cash from Operations 39.54M 336.94M 184.15M 230.29M 231.54M
Capital Expenditure -2.44M -1.66M -1.36M -1.06M -693.00K
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -254.58M -398.30M -298.13M -350.98M -156.20M
Cash from Investing -257.03M -399.96M -299.48M -352.05M -156.89M
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock 30.93M 30.58M 26.45M 22.95M 46.21M
Repurchase of Common Stock -479.00K -479.00K -600.00K -600.00K -600.00K
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash from Financing 30.45M 30.10M 25.85M 22.35M 45.61M
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -187.04M -32.92M -89.48M -99.41M 120.26M